MedPath
NMPA Approval

Atomoxetine Hydrochloride Capsules

国药准字HJ20160112

LILLY SA

August 13, 2020

H20160112

Drug Information

盐酸托莫西汀胶囊

择思达

胶囊剂

18mg

化学药品

August 13, 2020

August 12, 2025

Company Information

Applicant Company

LILLY SA

Avda.de la Industria,30 28108 ALCOBENDAS(MADRID),SPAIN

Manufacturing Company

lilly del caribe inc

Puerto Rico Industrial Park,12.6 km-65th Infantry Road Carolina PR 00985 PUERTO RICO

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸托莫西汀胶囊 - NMPA 批准文号 | MedPath